<DOC>
	<DOCNO>NCT01372397</DOCNO>
	<brief_summary>The overall purpose study determine weight loss beneficial obese patient diastolic heart failure .</brief_summary>
	<brief_title>Reversal Obesity Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>All subject obesity BMI &gt; 35kg/m2 . Subjects must age 35 65 year , order limit confound affect age endpoint . To determine potential subject meet criterion , : 1. interview , 2. clinical chart review , research study coordinator and/or PI , 3. undergo history physical physician ( Study Day 2 ) . Subjects undergo gastric bypass surgery intervention arm . They match control subject . We attempt one control subject gastric surgery subject . Subjects condition may masquerade diastolic heart failure exclude ( see Research Design ) . Subjects &lt; 35 &gt; 65 year , &gt; 400lbs ( weight limit MRI table ) obese , unstable , able lie flat imaging study , ambulatory , unable give inform consent , pregnant , lactating , atrial flutter fibrillation , current smoker , undergo different type bariatric surgery ( RouxenY gastric bypass ) exclude participation . Those evidence major systemic disease ( e.g. , cancer , significant lung disease , creatinine &gt; 2.0mg/dL , hemoglobin &lt; 10g/dL , liver function test twice normal range ) exclude . Subjects &gt; class I hypertension exclude . The investigator exclude patient LV ejection fraction &lt; 45 % significant pulmonary hypertension ( peak artery pressure &gt; 55mmHg ) .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>